Limit On Phytosterol CHD Health Claim Would Disrupt Industry – Cargill
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement industry stakeholders "urgently" ask FDA to continue allowing coronary heart disease reduction health claims for supplements with nonesterified phytosterols, or risk "irreparable injury" to some firms.